Introduction
A joint meeting was held January 30 through February 1, 1989 , between scientists from the U.S. National Toxicology Program (NTP), Research Triangle Park, NC, and the National Institute of Hygienic Sciences (NIHS), Tokyo, Japan, to exchange information on the scientific issues and processes involved in the design, conduct, and evaluation of both short-term and longterm toxicity/carcinogenicity studies.
As emphasized in the opening statements by Dr. Y. Omori (NIHS) and Dr. D. P. Rall (NTP), countries must work together in evaluating the toxicity of environmental chemicals in order to better protect public health throughout the world. This cooperation will minimize duplication of effort and will ensure better use of facilities, staff, and funds, hence allowing more chemicals to be evaluated more thoroughly.
Only a few of the 50,000 to 60,000 chemicals in common use have been studied adequately, and the worldwide production of synthetic organic chemicals has risen 300-fold during the last four decades. Only by countries working together can the number of chemicals evaluated be increased. Experimental evidence in the field of carcinogenesis coupled with epidemiological findings support the concept that results observed in laboratory animals can be used to predict probable results for humans. All chemicals known to induce cancer in humans that have been studied under adequate experimental conditions also cause cancer in animals (1) . An analysis of the International Agency for Research on Cancer (IARC) Information Bulletin on the Survey of Chemicals Being Tested for Carcinogenicity (2) , indicates that approximately 1200 chemicals are currently undergoing long-term chemical carcinogenicity studies in about 88 institutes in 20 countries. Of the studies listed, approximately 315 were being conducted by the NTP and 55 by the NIHS. Formal presentations on experimental programs to characterize chemical toxicity and carcinogenicity by U.S. and Japanese participants were followed by informal discussions. Brief summaries of the presentations follow in the next sections.
U.S. National Toxicology Program
The NTP was established in 1978 by the Department of Health and Human Services (DHHS) to coordinate and integrate both basic and applied toxicology research and testing activities within DHHS. The Program is mandated to: a) broaden the spectrum of toxicologic information obtained on chemicals selected and evaluated; b) increase the number ofchemicals and toxicologic end points evaluated, within resource limits; c) develop and validate a series of assay methods and protocols appropriate for regulatory needs; and d) communicate the plans and results to governmental agencies, the medical and scientific communities, and the public (3).
The NTP currently combines resources from three agencies within DHHS including the Centers for Disease Control (National Institute for Occupational Safety (4) . Detailed descriptions of the varied processes were presented and discussed at the joint meeting, and they can be found in several reports (4) (5) (6) (7) (8) (9) (10) health and safety, evaluates and then approves or modifies the study design.
In some instances, a study is designed to focus on a specific toxicological end point, but ordinarily the goal is a comprehensive toxicological characterization of the chemical including metabolism and disposition, genetic toxicity, fertility and reproductive assessment, carcinogenicity, and other toxic effects on specific target organs (e.g., immune or nervous system). Toxicologic characterization usually includes 14-day and 90 to 120 day studies, followed in many cases by 2-year studies. Studies are performed under contract to the NTP by qualified private laboratories or by another government agency or national laboratory. All of these studies are carried out under Good Laboratory Practices (GLP).
Chemical Pathology
Since pathology data often provide the end point for decisions concerning the potential hazards of a chemical, it is essential that such data be accurate and reflect current knowledge oflaboratory animal pathology. Both qualitative and quantitative pathology diagnoses must be considered. In typical 2-year carcinogenesis studies, 20,000 to 40,000 tissue sections are made for each chemical studied in both sexes of rats and mice. When the laboratory pathology evaluation is completed, the slides, individual animal data, and pathology tables are evaluated by an independent pathology quality assessment laboratory.
The quality assessment report and representative slides are subsequently reviewed by an ad hoc Pathology Working Group (PWG) composed of experienced members in rodent pathology, and the final diagnoses represent a consensus of study laboratory, quality assessment, and PWG pathologists (11) . This procedure has worked very successfully for the NTP and helps assure that the pathology aspects of the study are consistently evaluated.
Data Evaluation, Peer Review, and Dissemination
The principal statistical methods employed in NTP toxicology/carcinogenesis studies include survival analysis and mortality-adjusted evaluation of tumor incidence (12) . Although the statistical significance of an observed tumor increase is an important piece of evidence used in the evaluation process, other issues such as biologic significance, experimental design and conduct, false positives/false negatives, increasing/decreasing trends in tumor incidence, and the use of historical controls are also considered. Rigid statistical rules are not employed in the interpretation of carcinogenicity data, and biological mechanisms are always considered.
The quality assurance ofdata is an integral component of NTP Toxicological Studies at the BSRC The BSRC conducts various toxicological studies as a laboratory arm of the MHW, especially for the Ministry's Pharmaceutical Affairs Bureau and the Environmental Health Bureau. High priority chemicals to be studied at the BSRC are selected on the basis of public concern over human health. Usually the amount of production and use, biological and environmental effects, and the quality and quantity of previous toxicological data are considered before the final decision. The chemicals to be selected include medical drugs, food additives, agrochemicals, existing or new chemicals and household chemicals which are regulated, respectively, under the Pharmaceutical Affairs Law, Food Sanitation Law, Agricultural Chemical Regulation Law, Chemical Substances Control Act, and Household Chemicals Control Act. Also relevant are the Poisonous and Deleterious Substances Control Law and the Industrial Safety and Health Law. GLP standards have been applied for toxicity testing of medical drugs, agrochemicals, and existing or new chemicals since the early 1980s. The toxicity tests required for the safety evaluation of each category of chemicals are shown in Table 2 .
So far, approximately 900 chemicals or mixtures have been examined at the BSRC by various in vivo and/or in vitro toxicological tests. The numbers of each test conducted are listed in Table 3 . A total of 453 in vivo studies including 87 carcinogenicity tests has been conducted mainly by feeding (42%) or by gavage (31%). Others are by drinking, skin application, subcutaneous injection, inhalation, etc. As to test species, the rat (F344, Wistar, Sprague-Dawley) has been the most frequent one used, followed by the mouse (B6C3F1, ddY), rabbit, guinea pig, monkey, dog, and hamster. On some occasions, the tests required by the BSRC are conducted at outside facilities (universities, local Public Health Institutes, contract laboratories).
The test results obtained at the BSRC are submitted to the MHW as a Final Report, and raw data are also offered for further reference when required. The Final Report is examined by the officials of responsible divisions ofthe bureau and is used as scientific background data for their political management. Some of the Final Reports are also opened for discussion at the council for drugs, food, and others to obtain expert opinions before any final regulatory decision is made by the MHW. 
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Chemical Substances Control Act
This law was adopted in Japan in 1973 to strictly regulate chemicals that have properties of persistence and bioaccumulation and potential chronic toxicological effects that may be hazardous to humans. Until now, nine chemicals have been designated by Cabinet order as Specified Chemical Substances (i.e., PCB, PCN, HCB, aldrin, dieldrin, endrin, DDT, chlordane and heptachlor). However, in 1986 this law was revised to include chemicals that show properties of persistence but relatively low bioaccumulation (e.g., trichloroethylene). The new concept follows: a) Chemicals that do not accumulate in bioorganisms but have persistence and the potential to be harmful shall be designated as "Designated Chemical Substances," whose quantity of manufacture or import should be reported to the competent authority. b) Any one of the "Designated Chemical Substances" that prove to threaten environmental pollution and human health by a postmarketing surveillance shall be designated as a "Class-2 Specified Chemical Substances." c) The "Class-2 Specified Chemical Substances" shall be permitted for manufacture and import within a certain quantity ofthe "Class-2 Specified Chemical Substances" in question, if it causes environmental pollution and human health injury. d) "Specified Chemical Substances" defined by the old Law correspond to the "Class-1 Specified Chemical Substances" in the amended Law. Accordingly, the biodegradability test for persistence, n-octanol/water partition coefficient test for bioaccumulation and mutagenicity tests (gene mutation and chromosomal aberration) and 28-days repeated dose toxicity tests in animals as the screening toxicity tests were adopted for new chemicals. On the other hand, so-called "Full-scale Toxicology Tests" that are required mainly for existing chemicals, chronic toxicity, carcinogenicity, reproduction, teratogenicity, toxicokinetics, mutagenicity tests in vitro and in vivo, and pharmacological tests, are conducted. However, if a chemical is not persistent, the bioaccumulation test or the toxicity test shall not be required.
The revised law came into force on April, 1987, and the Safety Evaluation Committee of the MHW has evaluated 232 chemicals (204 new and 28 existing chemicals) to date. Among them, 32 chemicals have been classified as "Designated Chemical Substances" (Table 4 ). It should be mentioned that as of April, 1989, trichloroethylene, tetrachloroethylene, and carbon tetrachloride have been designated as "Class-2 Specified Chemical Substances" by the government.
Priority List Issued by the MHW
In 1988, a priority list consisting of 393 chemicals was issued by the MHW for identifying candidate existing chemicals for "Designated Chemical Substances." The chemicals selected are those that have already been determined by the Ministry of International Trade and Industry (MITI) to be persistent in the environment and to have low bioaccumulative properties. They are then divided into five groups, mainly based on toxicity data taken from the Registry of Toxic Effects of Chemical Substances and some from the U.S. NTP (chemicals in group 1 have the highest priority, and those in group 4 have the lowest priority). Chemicals in Group 5 are those for which appropriate toxicity data are not available. Toxicity data examined include outcomes from carcinogenicity, mutagenicity, reproductive/developmental toxicity, and general toxicity tests. icals in the environment, independent of the MHW. The survey is based on their own priority list, issued in 1978, of 2000 existing chemicals, using the criteria of persistence, bioaccumulation, and chronic toxicity. This survey is conducted through the following three stages:
In the first stage chemicals expected to have a high probability of persistence in the environment are selected (ca. 50/year). In the second stage, an environmental survey is conducted on these chemicals, and those showing persistence in the environment are chosen (ca. Future Perspectives at the BSRC The greater the increase in the numbers of chemicals in the environment, the more toxicity tests are required for safety evaluation. Actually some of the tests that would be conducted at the BSRC are transferred to outside facilities when available because of the lack of manpower, animal facilities, etc., at BSRC. Therefore a movement toward establishing a new system regarding chemical selection, toxicity testing, reporting, and evaluation is now in progress. In short, it can be called a modified Japanese-NTP, since the idea is very similar to the existing and very active U.S. NTP. Briefly, an Advisory Committee on the selection of priority chemicals for testing will be organized at first. When chemicals are nominated, the BSRC will determine the protocols for testing that will be conducted by the contract laboratories that are under strict GLP regulation. On the other hand, the BSRC will focus on conducting further fundamental studies on the toxicological mechanisms of chemicals that may have a high probability of affecting human health. The data from the outside sources will be collected at the BSRC for inspection by the Quality Assurance Unit and will then be evaluated by the Peer Review Committee, which consists of the BSRC staff as well as outside expertise. In fact, a new division tentatively called the Division of Comprehensive Evaluation will be responsible for the overall processes of the new system; it is being planned at the BSRC and will be started in the near future. The Final Report will be submitted to the MHW and then published in the scientific journals as soon as possible to be used by various organization in the world for safety/risk assessment.
In conclusion, we believe that close communication between NIEHS and the NIHS/BSRC is necessary to exchange up-to-date toxicological information. For that purpose, annual U.S.-Japan Joint Meetings by the professional staff of the two institutes will be highly beneficial.
Concluding Remarks
Dr. Y. Omori and Dr. D. P. Rail noted in their closing remarks that the meeting had been very productive. Through both formal presentations and informnal discussions, much information was exchanged about the respective programs of the NIHS and the NTP. Particular emphasis was placed on the similarities and differences in the approaches used by the two institutes. It was evident that although differences in the governmental organization and regulatory frameworks in each country resulted in unique national aspects (e.g., chemical selection procedures), the NIHS and NTP share many common objectives and methodologies in identifying the potential toxicity of a large variety of chemicals. The two countries will continue their joint efforts and avoid unnecessary duplication of effort. Priority lists of chemicals have been and will continue to be exchanged and examined in order to make recommendations to the respective national governments and international organizations on the need for toxicological evaluations of certain chemicals. Future joint meetings will continue to explore how best to implement collaborative efforts on the toxicological characterization of environmental chemicals of mutual interest.
